State Street Corp Merrimack Pharmaceuticals Inc Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 15, 2024	BUY	$13.06 - $15.0 $654,932 - $752,220	50,148 Added 25.49%	246,853 $3.65 Million
Q4 2023 Feb 14, 2024	BUY	$12.02 - $13.41 $58,429 - $65,186	4,861 Added 2.53%	196,705 $2.64 Million
Q3 2023 Nov 14, 2023	BUY	$11.6 - $12.52 $205,772 - $222,092	17,739 Added 10.19%	191,844 $2.37 Million
Q2 2023 Aug 14, 2023	BUY	$12.02 - $13.07 $1.49 Million - $1.61 Million	123,549 Added 244.38%	174,105 $2.14 Million
Q1 2023 May 15, 2023	BUY	$11.35 - $12.32 $19,295 - $20,944	1,700 Added 3.48%	50,556 $621,000
Q4 2022 Feb 14, 2023	BUY	$3.68 - $12.51 $8,464 - $28,773	2,300 Added 4.94%	48,856 $559,000
Q2 2021 Aug 16, 2021	BUY	$6.04 - $7.77 $213,640 - $274,832	35,371 Added 316.24%	46,556 $297,000
Q1 2020 May 11, 2020	BUY	$1.63 - $3.58 $18,231 - $40,042	11,185 New	11,185 $24,000

Others Institutions Holding MACK

# of Institutions

12

Shares Held

437K

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.